Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Lung Cancer. 2021 Jan 2;153:73–80. doi: 10.1016/j.lungcan.2020.12.032

Table 3.

HRs of mortality for KRASMUT LUAD patients and clinical characteristics from univariate and multivariate Cox regression analysis.

Covariate No. of patients No. of events Univariate analysis HR (95% CI) p Multivariate analysis HR (95% CI) p
LAKR: 0.021 0.011
 no 72 24 1 (reference) 1 (reference)
 yes 26 11 2.40 (1.1 – 4.90) 2.86 (1.28 – 6.40)
Age at diagnosis 0.61 0.77
 <65 46 17 1 (reference) 1 (reference)
 ≥ 65 52 18 0.84 (0.43 – 1.60) 1.07 (0.50 – 2.30)
Gender 0.14 0.24
 female 56 17 1 (reference) 1 (reference)
 male 42 18 1.70 (0.85 – 3.30) 1.49 (0.70 – 3.20)
Stage
 I 45 6 1 (reference) 1 (reference)
 II 28 16 3.50 (1.40 –8.50) 0.007 5.00 (1.86 – 13.50) 0.001
 III–IV 23 12 5.10 (2.00 – 13.20) < 0.001 6.25 (2.20 – 17.80) < 0.001
Smoking history
 <30 pack years 31 10 1 (reference) 1 (reference)
 ≥ 30 pack years 47 16 1.10 (0.51 – 2.50) 0.77 0.75 (0.32 – 1.80) 0.51
 unknown 20 20 1.10 (0.43 – 2.70) 0.88 1.12 (0.43 – 2.90) 0.81